Quarterly report pursuant to Section 13 or 15(d)

Segment Disclosures (Tables)

v3.21.2
Segment Disclosures (Tables)
9 Months Ended
Sep. 30, 2021
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information
Segment reporting information is as follows:
  EksoHealth EksoWorks Total
Three months ended September 30, 2021      
Revenue $ 2,716  $ 333  $ 3,049 
Cost of revenue 1,044  198  1,242 
Gross profit $ 1,672  $ 135  $ 1,807 
Three months ended September 30, 2020      
Revenue $ 2,739  $ 158  $ 2,897 
Cost of revenue 989  95  1,084 
Gross profit $ 1,750  $ 63  $ 1,813 

  EksoHealth EksoWorks Total
Nine months ended September 30, 2021      
Revenue $ 6,306  $ 864  $ 7,170 
Cost of revenue 2,326  510  2,836 
Gross profit $ 3,980  $ 354  $ 4,334 
Nine months ended September 30, 2020      
Revenue $ 6,015  $ 613  $ 6,628 
Cost of revenue 2,466  453  2,919 
Gross profit $ 3,549  $ 160  $ 3,709 
Schedule of Geographic Information Geographic information for revenue based on location of customers is as follows:
  Three Months Ended September 30, Nine Months Ended September 30,
  2021 2020 2021 2020
United States $ 1,777 $ 2,016 $ 3,914 $ 4,899
Other 25  14  105  59 
Americas 1,802  2,030  4,019  4,958 
Germany 313  131  845  509 
Belgium —  —  270  — 
Other 515  192  1,284  387 
EMEA 828  323  2,399  896 
APAC 419  544  752  774 
  $ 3,049  $ 2,897  $ 7,170  $ 6,628